Commentary: Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor

Detalles Bibliográficos
Autores principales: Majagi, Shreya, Mangat, Sharan, Chu, Xiang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294732/
https://www.ncbi.nlm.nih.gov/pubmed/35865964
http://dx.doi.org/10.3389/fphar.2022.938748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294732/
https://www.ncbi.nlm.nih.gov/pubmed/35865964
http://dx.doi.org/10.3389/fphar.2022.938748

Ejemplares similares